Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis Dec 11, 2014 04:01PM
Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis Nov 25, 2014 04:01PM
Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis Nov 11, 2014 04:01PM
Notable 52-Week Highs and Lows of the Day 9/25: (IG) (FB) (RLGT) High; (BAXS) (SWFT) (FUL) Low Sep 25, 2014 02:53PM
Top 10 News for 05/27 - 05/30: Hillshire's Bidding War; Apple's Got the 'Beats'; More Love for Twitter May 30, 2014 03:52PM


Sep 20, 2013 12:21PM Alexza's EU Partner (Grupo Ferrer) Signs New ADASUVE Deal With Medivir